Trials / Recruiting
RecruitingNCT05794022
Cohort of STEMI Patients 2
CoHort of Patients to Identify Biological and Imaging markerS of CardiovascUlar Outcomes in ST Elevation Myocardial Infarction
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
ST-segment elevation myocardial infarction (STEMI) is an acute condition that accounts for 75% of sudden deaths in adults over 35 years of age and more than half of all cases of chronic heart failure. However, the mechanism of myocardial infarction remains poorly understood. At present, there is no national information system for myocardial infarction, as there is for other diseases such as multiple sclerosis (OFSEP cohort). The purpose of this cohort is to enable studies and research projects to be carried out on the descriptive epidemiology of myocardial infarction, monitoring of patients undergoing treatment (safety, efficacy), quality of life and functional consequences of infarction, and research into new biological and imaging prognostic biomarkers. Its general objective is to provide researchers, hospital practitioners, medical interns, academics or industrialists with a quality epidemiological tool for research.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | MRI | 1 MRI at 1 month with gadolinium injection |
| BIOLOGICAL | Biocollection | Biocollection from blood (H0, H4, H24, H48, 1 month, 1 year), urine (H48) and faecal (initial hospitalisation) samples. |
| BEHAVIORAL | Quality of life questionaries | EQ-5D-5L and HAD questionaries at 1 month and 1 year. |
Timeline
- Start date
- 2023-05-03
- Primary completion
- 2031-06-03
- Completion
- 2031-06-03
- First posted
- 2023-03-31
- Last updated
- 2026-01-30
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05794022. Inclusion in this directory is not an endorsement.